Sandra Rieger, Ph.D., conducts peripheral neuropathy research at MDI Biological Laboratory. A recent attendee of the Foundation for Peripheral Neuropathy 2016 International Research Symposium in Chicago, she recently wrote a post for the MDI Biological Laboratory’s blog, “Breaking Through,” that addresses in part her experiences at our symposium. Dr. Rieger’s article, The Patient Perspective: How […]
Read More… from Peripheral Neuropathy Research – Valuing the Patient’s Perspective
by Dr. Thomas Smith and Dr. Charles Loprinzi What is neuropathic pain, from the non-expert oncologist’s point of view? The way we think of it, pain is about the most protective instinct and impulse known to humans! If you touch a hot plate, you retract your hand even before you actually feel the pain. Then, the […]
Read More… from Scrambler Therapy for Treating Neuropathic Pain
Summary of journal article reviewing the current state of diabetic peripheral neuropathy treatment: Painful diabetic peripheral neuropathy occurs in approximately 25% of patients with diabetes mellitus who are treated in the office setting and significantly affects quality of life. It typically causes burning pain, paresthesias, and numbness in a stocking-glove pattern that progresses proximally from […]
Read More… from Treating Painful Diabetic Peripheral Neuropathy: An Update
Genetic Bio Marker may Predict Chemo-Induced Peripheral Neuropathy Side Effects Associated with Prostate Cancer Treatment New study finds genetic alterations in the VAC14 gene are associated with an increased risk of chemo-induced peripheral neuropathy in prostate cancer patients. Taxanes are a group of drugs commonly used to treat cancers of the breast, lung, ovary, or prostate, […]
Read More… from Chemo-Induced Peripheral Neuropathy may be Predicted by Genetic Bio Marker
A team of researchers at The University of Texas MD Anderson Cancer Center (TX, USA) have discovered a link between the use of neurofeedback and a decrease in personal experience of chronic pain in patients with chronic chemotherapy-induced peripheral neuropathy (CIPN). The results help to expand knowledge of neuropathic pain and a chemotherapy side effect that […]
Genetic testing can help doctors identify the causes of hereditary and idiopathic neuropathies. Genetic testing is a type of medical test that identifies changes in chromosomes, genes, or proteins. The results of a genetic test can confirm or rule out a suspected genetic condition or help determine a person’s chance of developing or passing on […]
On December 3, 2015, Astellas Pharma US, Inc. (the U.S. affiliate of Astellas Pharma Inc.), a R&D-driven global pharmaceutical company, invited the Foundation for Peripheral Neuropathy to present to a global team working on development of ASP3662 for patients with neuropathic pain (NP). This was an internal meeting, which included Ulf Tollemar, Executive Director, Development […]
Flu season is upon us. At this time of year the Foundation frequently receives inquiries about the safety of getting the flu vaccine if a patient has peripheral neuropathy – especially peripheral neuropathy patients with underlying immune issues. **This information is intended for general educational purposes only. Any decisions regarding vaccinations should be made in […]
Neuropathy is a common side effect of certain medications, especially those used in chemotherapy to fight cancer like cisplatin, carboplatin, and oxaliplatin. While symptoms might disappear over time, for some the shooting pain or a loss of feeling in the hands and feet may become chronic. A recent study investigated the effects of Botox B, […]
Read More… from Nerve Pain Therapy: Botox May Treat Peripheral Neuropathy in Cancer Patients
Scientists at Washington University School of Medicine in St. Louis, reported new research that highlights how nerves – whether harmed by disease or traumatic injury – start to die, a discovery that unveils novel targets for developing drugs to slow or halt peripheral neuropathies and devastating neurodegenerative disorders such as…READ MORE Source: News Medical […]
Read More… from Discovery Unveils Novel Drug Targets to Halt Peripheral Neuropathies…